The novel peptide exhibits a higher sensitivity than any other known diagnostic test for celiac disease. It features the detection by antibodies from patient sera under denaturated conditions, which allows the design of various assay formats of diagnostic kits.
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Ursula Haufe
